Navigation Links
ClinStar to Present on Russia's Performance as an Emerging Market in Global Clinical Trials
Date:9/15/2011

SAN FRANCISCO, Sept. 15, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that Manager of Clinical Operations Alexander Kutermin will speak at VIBpharma's Outsourcing in Clinical Trials New England conference, September 28-29, at The Boston Park Plaza Hotel & Towers in Boston, MA.  

(Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO)

The paradigm of traditional drug development is shifting as more and more pharmaceutical and biotech organizations look to emerging markets to reduce their clinical study timelines, and hence overall development costs, through more effective patient enrollment. During the presentation scheduled for Wednesday, September 28 at 3:00 p.m., Mr. Kutermin will explore perceptions of emerging markets, evaluate Russia's clinical trial climate in comparison to other emerging countries and learn how to navigate Russia's regulations in order to ensure study success. The presentation will feature a real-life case study evaluating Russia's performance compared to two other regions in a global phase II clinical trial.

VIBpharma's Outsourcing in Clinical Trials New England conference prides itself in offering an expertly designed intelligence and networking platform to discuss pressing industry issues and provide practical solutions to the greatest challenges in clinical outsourcing. With more than 25 sessions, pharmaceutical and biotechnology participants at this year's conference will discuss unparalleled partnership strategies; value propositions in vendor selection; innovative methods to optimize patient enrollment; regulatory challenges; profitable budget management, trial costing and alternative pricing structures; expanded clinical development; emerging markets; and best practices for heightened vigilance in outsourced clinical trials.

About ClinStar, LLC

ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.


'/>"/>
SOURCE ClinStar, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ClinStar, LLC Establishes New Office on the US East Coast
2. ClinStar to Present on Conducting Clinical Trials in Russia
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan 17, 2017 Research and Markets ... Materials: 2017 - 2024" report to their offering. ... This new report revisits ... report that was issued in May of 2015. Self-healing is an ... our previous analysis we projected a market potential of $2.7 billion ...
(Date:1/17/2017)... , Jan. 17, 2017 Paragon Bioservices ... provide product development services for a variety of ... (NIAID) medical product development activities. The IDIQ ... contractor pool for task order awards up to ... leader in manufacturing and process development of biopharmaceuticals, ...
(Date:1/17/2017)... 2017 Management to Discuss Acquisition of ... KIT-302 Development On Track For An NDA ... in Q1 2017   ... Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an innovative biopharmaceutical ... 23 rd at 8:30am Eastern Time to discuss the recent acquisition of ...
Breaking Medicine Technology:
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 , ... ... grand opening of a new showroom at South Dixie Hwy in Miami, FL. , ... Officer at Gym Source. “The new innovative in-store concept is designed to give clients ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance ... The company, owned and operated by Ed Stroup, was created to offer the ... the highest level of customer service. Healthful Balance products can be purchased online ...
(Date:1/17/2017)... ... 17, 2017 , ... Metro Development Group has broken ground ... technology into the fabric of an entire community. A highlight of this new ... in a yet-to-be-named, health focused campus. Leading this initiative in partnership with Metro ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... joined the Peoples Health network on Dec. 1, 2016. Peoples Health, a ... Senior Medical Center is an exciting addition to our provider network, and the ...
(Date:1/17/2017)... ... , ... Neil H. Greco Insurance Agency, a northern New Jersey firm that ... launching a charity drive to raise awareness of heart disease and promote habits that ... and is responsible for 1 in every 4 deaths at the national level each ...
Breaking Medicine News(10 mins):